Venmax Drugs And Pharmaceuticals Ltd. announced earnings results for the second quarter ended September 30, 2018. For the second quarter, the company announced sales was INR 112,000 compared to INR 0 a year ago. Net loss was INR 893,000 compared to INR 364,000 a year ago. Basic loss per share was INR 0.17 compared to INR 0.07 a year ago. For the half year, sales was INR 112,000 compared to INR 0 a year ago. Net loss was INR 1.078 million compared to INR 532,000 a year ago. Basic loss per share was INR 0.21 compared to INR 0.1 a year ago.